ZYDUS LIFESCIENCES Financial Statement Analysis
|
||
The Revenues of ZYDUS LIFESCIENCES have increased by 14.08% YoY .
The Earnings Per Share (EPS) of ZYDUS LIFESCIENCES has decreased by -55.80 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
ZYDUS LIFESCIENCES Last 5 Annual Financial Results
[BOM: 532321|NSE : ZYDUSLIFE]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹17,237 Cr | ₹15,110 Cr | ₹14,404 Cr | ₹14,253 Cr | ₹13,166 Cr |
Expenses | ₹13,666 Cr | ₹11,935 Cr | ₹11,018 Cr | ₹11,473 Cr | ₹10,187 Cr |
Operating Profit (Excl OI) | ₹3,572 Cr | ₹3,175 Cr | ₹3,385 Cr | ₹2,780 Cr | ₹2,978 Cr |
Other Income | ₹475 Cr | ₹391 Cr | ₹75 Cr | ₹117 Cr | ₹209 Cr |
Interest | ₹130 Cr | ₹127 Cr | ₹186 Cr | ₹342 Cr | ₹196 Cr |
Depreciation | ₹723 Cr | ₹713 Cr | ₹670 Cr | ₹697 Cr | ₹599 Cr |
Profit Before Tax | ₹2,590 Cr | ₹2,838 Cr | ₹2,399 Cr | ₹1,495 Cr | ₹2,382 Cr |
Profit After Tax | ₹2,002 Cr | ₹2,326 Cr | ₹2,206 Cr | ₹1,176 Cr | ₹1,852 Cr |
Consolidated Net Profit | ₹1,960 Cr | ₹4,487 Cr | ₹2,134 Cr | ₹1,177 Cr | ₹1,849 Cr |
Earnings Per Share (Rs) | ₹19.37 | ₹43.82 | ₹20.84 | ₹11.49 | ₹18.05 |
PAT Margin (%) | 5.90 | 7.87 | 7.64 | 8.25 | 14.07 |
ROE(%) | 11.60 | 15.51 | 18.88 | 11.32 | 19.36 |
ROCE(%) | 13.64 | 15.30 | 14.38 | 10.02 | 15.89 |
Total Debt/Equity(x) | 0.07 | 0.25 | 0.35 | 0.77 | 0.76 |
Key Financials |
||
Market Cap | : | ₹ 93,918.7 Cr |
Revenue (TTM) | : | ₹ 19,024.2 Cr |
Net Profit(TTM) | : | ₹ 2,954.2 Cr |
EPS (TTM) | : | ₹ 29.4 |
P/E (TTM) | : | 31.8 |
Industry Peers & Returns | 1W | 1M | 1Y |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
AUROBINDO PHARMA | 6.4% | 0.8% | 117.4% |
ZYDUS LIFESCIENCES Revenues
[BOM: 532321|NSE : ZYDUSLIFE]
Y-o-Y | 14.08 % |
5 Yr CAGR | 6.97 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹17,237 Cr | 14.08 | |
Mar2022 | ₹15,110 Cr | 4.90 | |
Mar2021 | ₹14,404 Cr | 1.06 | |
Mar2020 | ₹14,253 Cr | 8.26 | |
Mar2019 | ₹13,166 Cr | - |
ZYDUS LIFESCIENCES Operating Profit
[BOM: 532321|NSE : ZYDUSLIFE]
Y-o-Y | 12.51 % |
5 Yr CAGR | 4.65 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹3,572 Cr | 12.51 | |
Mar2022 | ₹3,175 Cr | -6.22 | |
Mar2021 | ₹3,385 Cr | 21.76 | |
Mar2020 | ₹2,780 Cr | -6.65 | |
Mar2019 | ₹2,978 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -1.38 % |
5 Yr CAGR | -2.17 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 20.72% | -1.38 | |
Mar2022 | 21.01% | -10.60 | |
Mar2021 | 23.5% | 20.45 | |
Mar2020 | 19.51% | -13.75 | |
Mar2019 | 22.62% | - |
ZYDUS LIFESCIENCES Profit After Tax
[BOM: 532321|NSE : ZYDUSLIFE]
Y-o-Y | -56.31 % |
5 Yr CAGR | 1.47 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹1,960 Cr | -56.31 | |
Mar2022 | ₹4,487 Cr | 110.32 | |
Mar2021 | ₹2,134 Cr | 81.34 | |
Mar2020 | ₹1,177 Cr | -36.36 | |
Mar2019 | ₹1,849 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -25.03 % |
5 Yr CAGR | -19.53 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 5.9 % | -25.03 | |
Mar2022 | 7.87 % | 3.01 | |
Mar2021 | 7.64 % | -7.39 | |
Mar2020 | 8.25 % | -41.36 | |
Mar2019 | 14.07 % | - |
ZYDUS LIFESCIENCES Earnings Per Share (EPS)
[BOM: 532321|NSE : ZYDUSLIFE]
Y-o-Y | -55.80 % |
5 Yr CAGR | 1.78 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹19 | -55.80 | |
Mar2022 | ₹44 | 110.27 | |
Mar2021 | ₹21 | 81.38 | |
Mar2020 | ₹11 | -36.34 | |
Mar2019 | ₹18 | - |
ZYDUS LIFESCIENCES Return on Capital Employed (ROCE)
[BOM: 532321|NSE : ZYDUSLIFE]
Y-o-Y | -10.85 % |
5 Yr CAGR | -3.75 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 13.64% | -10.85 | |
Mar2022 | 15.3% | 6.40 | |
Mar2021 | 14.38% | 43.51 | |
Mar2020 | 10.02% | -36.94 | |
Mar2019 | 15.89% | - |
ZYDUS LIFESCIENCES Share Price vs Sensex
Current Share Price | : | ₹933.4 |
Current MarketCap | : | ₹ 93,918.7 Cr |
Updated EOD on | : | Apr 24,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | 5% |
10.4% |
109.1% |
SENSEX | 1.3% |
2.6% |
24% |
ZYDUS LIFESCIENCES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 400 MIDSMALLCAP | 1.9% | 9.9% | 59.4% |
S&P BSE 150 MIDCAP | 1.6% | 8.5% | 56.7% |
S&P BSE ALLCAP | 1.6% | 6% | 40.6% |
S&P BSE 500 | 1.4% | 5.5% | 38.5% |
S&P BSE 250 LARGEMIDCAP | 1.3% | 4.8% | 36.3% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY NEXT 50 | 2% | 10.2% | 64.5% |
NIFTY500 MULTICAP 50:25:25 | 1.8% | 7.7% | 48.1% |
NIFTY 500 | 1.5% | 5.7% | 39.5% |
NIFTY LARGE MIDCAP 250 | 1.5% | 6.5% | 45% |
NIFTY 100 EQUAL WEIGHT | 1.4% | 6.2% | 51% |
You may also like the below Video Courses
FAQ about ZYDUS LIFESCIENCES Financials
How the annual revenues of ZYDUS LIFESCIENCES have changed ?
The Revenues of ZYDUS LIFESCIENCES have increased by 14.08% YoY .
How the Earnings per Share (EPS) of ZYDUS LIFESCIENCES have changed?
The Earnings Per Share (EPS) of ZYDUS LIFESCIENCES has decreased by -55.80 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs